Bluejay Diagnostics, Inc. earnings releases BJDX

Annual Quarterly

Bluejay Diagnostics, Inc. last reported quarterly results on May 7, 2026, for Q1 FY2026 (the quarter ended Mar 31, 2026): diluted EPS of -$1.95. It usually reports 37–65 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 37–65 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released	Quarter	Revenue	Net income	Diluted EPS
May 7, 2026 37 days after quarter end	Q1 FY2026 ended Mar 31, 2026	—	-2 -2.9%	-1.95 +85.5%
Mar 6, 2026 65 days after quarter end	Q4 FY2025 ended Dec 31, 2025	—	-1 +0.2%	0.85 -98.7%
Nov 9, 2023 40 days after quarter end	— ended Sep 30, 2023	—	—	—
Aug 16, 2023 47 days after quarter end	— ended Jun 30, 2023	—	—	—
May 10, 2023 40 days after quarter end	— ended Mar 31, 2023	—	—	—
Nov 8, 2022 39 days after quarter end	— ended Sep 30, 2022	—	—	—
Jul 26, 2022 26 days after quarter end	— ended Jun 30, 2022	—	—	—
Apr 20, 2022 20 days after quarter end	— ended Mar 31, 2022	—	—	—

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: BJDX (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Acton, MA
SEC filer status: , Emerging growth company
SEC CIK: 1704287

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.